Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?

NCT07295522 is registered in ClinicalTrials.gov with IRCCS Policlinico S. Donato as lead sponsor.

NCT NCT07295522
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07295522 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacological Optimization in Prevention in Heart Failure: A Sex-gap?
Lead sponsor
IRCCS Policlinico S. Donato
Phase
Phase 4
Overall status
Not yet recruiting
Start date
April 8, 2026
Completion date
June 8, 2028
Enrollment
368 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute heart failure, heart failure, heart failure with mildly reduced ejection fraction, heart failure with preserved ejection fraction (hfpef), heart failure with reduced ejection fraction (hfref)